Xwell (XWEL) Total Non-Current Liabilities (2010 - 2025)

Xwell (XWEL) posted Total Non-Current Liabilities of $17.5 million for Q3 2025, up 1.49% sequentially from $17.3 million in Q2 2025.

Xwell (XWEL) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

Xwell has reported Total Non-Current Liabilities for 12 years, with the latest figure at $17.5 million in Q3 2025.

Quarterly Total Non-Current Liabilities changed N/A year-over-year to $17.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $17.5 million (changed N/A YoY) and the FY2020 annual result came in at $7.4 million, down 73.8% from the prior year.
Total Non-Current Liabilities advanced to $17.5 million in Q3 2025 per XWEL's latest filing, from $17.3 million in the prior quarter.
Over five years, Total Non-Current Liabilities peaked at $18.1 million in Q1 2025 and troughed at $17.3 million in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Non-Current Liabilities (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn	108.64 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn	85.84 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn	715.49 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn	5.45 Bn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn	22.94 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn	542.10 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn	6.36 Bn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn	3.39 Bn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn	9.19 Bn
10	Xwell	8.44 Mn	-3.33 Mn	2.95 Mn	-

Download Data